Stuart M. Pape

February 19, 2025 Publications

MAHA Commission expected to impact approach to medications, vaccines, research

Quoted, McKnights Senior Living

Stuart Pape, Chad Landmon and Michael Gaba discuss how the MAHA Commission's approach to medications, vaccines and research could impact costs, FDA policy and approval times and more.

Resources

Read the full article

Firm Highlights

Slide 1 of 6

Event
2026 Business Law Institute Virtual Series | Part 2
The presentation addresses the tax-driven considerations in terms of an M&A process.
Read more
Blog
2026 Mid-Year Employment Law Updates
Read more
Publication
California Expands Antitrust Law, Increasing Exposure for Companies with Market Power
California enacted the COMPETE Act on Sept. 30, expanding the Cartwright Act to cover certain monopolization and monopsonization conduct while limiting enforcement of the new provision to the California attorney general and district attorneys.
Read more
News
Polsinelli Secures Federal Circuit Win for TCO in Patent Appeal
Polsinelli secured a significant appellate victory for client TCO Group (TCO) before the U.S. Court of Appeals for the Federal Circuit, which vacated a judgment that two asserted patent claims were not invalid and remanded the matter for further proceedings.
Read more
Publication
Delaware Court Extends Hikma to Labels Without Carve-Outs
In one of the first life sciences cases to address induced infringement after Hikma v. Amarin, the District of Delaware held that its affirmative-conduct standard applies even when a generic uses the full reference label, rejecting Vanda’s argument that Hikma is limited to skinny-label carve-outs.
Read more
News
Polsinelli Names David Karp as Chair of Restructuring & Strategic Capital Practice, Andrew Nazar as Vice Chair
Polsinelli today announced its rebranded and expanded Restructuring & Strategic Capital Practice, naming David J. Karp Chair and Andrew J. Nazar Vice Chair as the group builds a premier offering specifically designed for the middle-market.
Read more

MAHA Commission expected to impact approach to medications, vaccines, research

Resources

Related Capabilities